Skip to main content
SpringerLink
Log in

Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system

  • Review
  • Artificial Liver, Pancreas
  • Published:
Journal of Artificial Organs Aims and scope Submit manuscript

Abstract

The incidence of diabetes is increasing at an unprecedented pace and has become a serious health concern worldwide during the last two decades. Despite this, adequate glycemic control using an artificial pancreas has not been established, although the 21st century has seen rapid developments in this area. Herein, we review current topics in glycemic control for both the wearable artificial pancreas for type 1 and type 2 diabetic patients and the bedside artificial pancreas for surgical diabetic patients. In type 1 diabetic patients, nocturnal hypoglycemia associated with insulin therapy remains a serious problem that could be addressed by the recent development of a wearable artificial pancreas. This smart phone-like device, comprising a real-time, continuous glucose monitoring system and insulin pump system, could potentially significantly reduce nocturnal hypoglycemia compared with conventional glycemic control. Of particular interest in this space are the recent inventions of a low-glucose suspend feature in the portable systems that automatically stops insulin delivery 2 h following a glucose sensor value <70 mg/dL and a bio-hormonal pump system consisting of insulin and glucagon pumps. Perioperative tight glycemic control using a bedside artificial pancreas with the closed-loop system has also proved safe and effective for not only avoiding hypoglycemia, but also for reducing blood glucose level variability resulting in good surgical outcomes. We hope that a more sophisticated artificial pancreas with closed-loop system will now be taken up for routine use worldwide, providing enormous relief for patients suffering from uncontrolled hyperglycemia, hypoglycemia, and/or variability in blood glucose concentrations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Vashist SK. Continuous glucose monitoring systems: a review. Diagnostics. 2013;3:385–412.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Hanazaki K, Nosé Y, Brunicardi FC. Artificial endocrine pancreas: a review. J Am Coll Surg. 2001;193:310–22.

    Article  CAS  PubMed  Google Scholar 

  3. Phillip M, Battelio T, Atlas E, et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med. 2013;368:824–33.

    Article  CAS  PubMed  Google Scholar 

  4. Bergenstal RM, Klonoff DC, Garg SK, et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med. 2013;369:224–32.

    Article  CAS  PubMed  Google Scholar 

  5. Hovorka R, Elleri D, Thabit H, et al. Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care. 2014;37:1204–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Russell SJ, El-Khatib FH, Sinha M, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med. 2014;371:313–25.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Thabit H, Tauschmann M, Allen JM, et al. Home use of an artificial beta cell in type 1 diabetes. N Engl J Med. 2015;373:2129–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67.

    Article  PubMed  Google Scholar 

  9. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults. JAMA. 2008;300:933–44.

    Article  CAS  PubMed  Google Scholar 

  10. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–97.

    Article  Google Scholar 

  11. Hanazaki K, Maeda H, Okabayashi T. Tight perioperative glycemic control using an artificial endocrine pancreas. Surg Today. 2010;40:1–7.

    Article  PubMed  Google Scholar 

  12. Yatabe T, Yamazaki R, Kitagawa H, et al. The evaluation of the ability of closed-loop glycemic control device to maintain the blood glucose concentration in intensive unit patients. Crit Care Med. 2011;39:575–8.

    Article  CAS  PubMed  Google Scholar 

  13. Hanazaki K, Kitagawa H, Yatabe T, et al. Perioperative intensive insulin therapy using an artificial endocrine pancreas with closed-loop glycemic control system: the effect of no hypoglycemia. Am J Surg. 2014;207:935–41.

    Article  PubMed  Google Scholar 

  14. Guillod L, Comte-Perret S, Monbaron D, Gaillard RC, Ruiz J. Nocturnal hypoglycemias in type 1 diabetic patients: what we can leran with continuous glucose monitoring? Diabetes Metab. 2007;33:360–5.

    Article  CAS  PubMed  Google Scholar 

  15. Maia FFR, Araujo LR. Effect of continuous glucose monitoring system (CGMS) to detect postprandial hyperglycemia and unrecognized hypoglycemia in type 1 diabetic patients. Diabetes Res Clin Pract. 2007;75:30–4.

    Article  CAS  PubMed  Google Scholar 

  16. Kaufman FR, Gibson LC, Halvorson M, Carpenter S, Fisher LK, Pitukcheewanont P. A pilot study of the continuous glucose monitoring system. Diabetes Care. 2001;24:2030–4.

    Article  CAS  PubMed  Google Scholar 

  17. Fatourechi MM, Kudva YC, Murad MH, et al. Hypoglycemia with intensive insulin therapy: a systematic review and meta analyses of randomized trials of CSII versus MDI. J Clin Endocrinol Metab. 2009;94:729–40.

    Article  CAS  PubMed  Google Scholar 

  18. Jeitler K, Horvath K, Berghold A, et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systemic review and meta-analysis. Diabetologia. 2008;51:941–51.

    Article  CAS  PubMed  Google Scholar 

  19. Monami M, Lamanna C, Marchionni N, et al. CSII versus MDI in type 1 diabetes: a meta-analysis. Acta Diabetol. 2010;47:77–81.

    Article  CAS  PubMed  Google Scholar 

  20. Fredheim S, Johansen A, Thorsen SU, et al. Nationwide reduction in the frequency of severe hypoglycemia by half. Acta Diabetol. 2014;52:591–9.

    Article  PubMed  Google Scholar 

  21. Steineck I, Cederholm J, Eliasson B, et al. Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18168 people with type 1 diabetes: observational study. BMJ. 2015;350:h3234.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Garg S, Brazg RL, Bailey TS, et al. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Techol Ther. 2012;14:205–9.

    Article  CAS  Google Scholar 

  23. Haidar A, Legault L, Mateau-Pelletier L, et al. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomized controlled trial. Lancet Diabetes Endocrinol. 2015;3:595–604.

    Article  CAS  PubMed  Google Scholar 

  24. Haidar A, Legault L, Messier V, Mitre TM, Leroux C, Rabasa-Lhoret R. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomized controlled crossover trial. Diabetes Endocrinol. 2015;3:17–26.

    CAS  Google Scholar 

  25. Leelarathna L, Dellweg S, Mader JK, et al. Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study. Diabetes Care. 2014;37:1931–7.

    Article  CAS  PubMed  Google Scholar 

  26. Nimri R, Muller I, Atlas E, et al. MD-Logic overnight control 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial. Diabetes Care. 2014;37:3025–32.

    Article  CAS  PubMed  Google Scholar 

  27. Thabit H, Lubina-Solomon A, Stadler M, et al. Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomized crossover study. Lancet Diabetes Endocrinol. 2014;2:701–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Hermanides J, Engström AE, Wentholt IM, et al. Sensor-augmented insulin pump therapy to treat hyperglycemia at the coronary care unit: a randomized clinical pilot trial. Diabetes Technol Ther. 2010;12:537–42.

    Article  CAS  PubMed  Google Scholar 

  29. Rosenlund S, Hansen TW, Rossing P, Andersen S. Effect of sensor-augmented pump treatment versus multiple daily injections on albuminuria: a 1-year randomized study. J Clin Endocrinol Metab. 2015;100:4181–8.

    Article  CAS  PubMed  Google Scholar 

  30. Tsukamoto Y, Okabayashi T, Hanazaki K. Progressive artificial endocrine pancreas: the era of novel perioperative blood glucose control for surgery. Surg Today. 2011;41:1344–51.

    Article  CAS  PubMed  Google Scholar 

  31. Tsukamoto Y, Kinoshita Y, Kitagawa H, et al. Evaluation of a novel artificial pancreas: closed loop glycemic control system with continuous blood glucose monitoring. Artif Organ. 2013;37:E67–73.

    Article  CAS  Google Scholar 

  32. Yamashita K, Okabayashi T, Yokoyama T, et al. The accuracy of continuous blood glucose monitor during surgery. Anesth Analg. 2008;106:160–3.

    Article  PubMed  Google Scholar 

  33. Yamashita K, Okabayashi T, Yokoyama T, et al. Accuracy and reliability of continuous blood glucose monitor in post-surgical patients. Acta Anaesthesiol Scand. 2009;53:66–71.

    Article  CAS  PubMed  Google Scholar 

  34. Hanazaki K, Maeda H, Okabayashi T. Relationship between perioperative glycemic control and postoperative infections. World J Gastroenterol. 2009;15:4122–5.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Hanazaki K. Tight glycemic control using an artificial endocrine pancreas may play an important role in preventing infection after pancreatic resection. World J Gastroenterol. 2012;18:3787–9.

    Article  CAS  PubMed Central  Google Scholar 

  36. Finney SJ, Zekveld C, Elia A, et al. Glucose control and mortality in critically ill patients. JAMA. 2003;290:2041–7.

    Article  CAS  PubMed  Google Scholar 

  37. Rady MY, Johnson DJ, Patel BM, et al. Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. Mayo Clin Proc. 2005;80:1558–67.

    Article  PubMed  Google Scholar 

  38. Gabbanelli V, Pantanetti S, Donati A, et al. Correlation between hyperglycemia and mortality in a medical and surgical intensive care unit. Minerva Anestesiol. 2005;71:717–25.

    CAS  PubMed  Google Scholar 

  39. Ata A, Lee J, Bestle SL, et al. Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg. 2010;145:858–64.

    Article  PubMed  Google Scholar 

  40. Eshuis WJ, Hermanides J, van Dalen JW, et al. Early postoperative hyperglycemia is associated with postoperative complications after pancreatoduodenectomy. Ann Surg. 2011;253:739–44.

    Article  PubMed  Google Scholar 

  41. van den Berghe G. Insulin therapy in the intensive care unit should be targeted to maintain blood glucose between 4.4 and 6.1 mmol/l. Diabetologia. 2008;51:911–5.

    Article  PubMed  Google Scholar 

  42. Kono T, Hanazaki K, Yazawa K, et al. Pancreatic polypeptide administration reduces insulin requirements of artificial pancreas in pancreatectomized dogs. Artif Organs. 2005;29:83–7.

    Article  PubMed  Google Scholar 

  43. Workgroup on Hypoglycemia. American diabetes association. defining and reporting hypoglycemia in diabetes: a report from the american diabetes association workgroup on hypoglycemia. Diabetes Care. 2005;28:1245–9.

    Article  Google Scholar 

  44. Hanazaki K, Yatabe T, Kobayashi M, et al. Perioperative glycemic control using an artificial endocrine pancreas in patients undergoing total pancreatectomy: tight glycemic control may be justified in order to avoid brittle diabetes. Biomed Mat Eng. 2013;23:109–16.

    CAS  Google Scholar 

  45. Mibu K, Yatabe T, Hanazaki K. Blood glucose control using an artificial pancreas reduces the workload of ICU nurses. J Artif Organs. 2012;15:71–6.

    Article  Google Scholar 

  46. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105:244–52.

    Article  CAS  PubMed  Google Scholar 

  47. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008;36:3008–13.

    Article  CAS  PubMed  Google Scholar 

  48. Hermanides J, Vriesendrop TM, Bosman RJ, Zandstra DF, Hoekstra JB, Devries JH. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38:838–42.

    Article  CAS  PubMed  Google Scholar 

  49. Mackenzie IMJ, Whitehouse T, Nightingale PG. The metrics of glycaemic control in critical care. Intensive Care Med. 2011;37:435–43.

    Article  CAS  PubMed  Google Scholar 

  50. Munekage M, Yatabe T, Kitagawa H, et al. An artificial pancreas provided a novel model of blood glucose level variability in beagles. J Artif Organs. 2015;18(4):387–90.

    Article  CAS  PubMed  Google Scholar 

  51. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Phys. 1979;237:E214–23.

    CAS  Google Scholar 

  52. Kwon S, Thompson R, Dellinger P, et al. Importance of perioperative glycemic control in general surgery: a report from the surgical care and outcomes assessment program. Ann Surg. 2013;257:8–14.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Frisch A, Chandra P, Smiley D, et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care. 2010;33:1783–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Kotagal M, Symons RG, Hirsch IB, et al. Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Ann Surg. 2015;261:97–103.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Munekage M, Yatabe T, Sakaguchi M, et al. Comparison of subcutaneous and intravenous continuous glucose monitoring accuracy in an operating room and an intensive care unit. J Artif Organs. 2015. doi:10.1007/s10047-015-0877-2.

    Google Scholar 

  56. Malchesky PS. Artificial organs and vanishing boundaries. Artif Organs. 2001;25:75–8.

    Article  CAS  PubMed  Google Scholar 

  57. Malchesky PS. Artificial organs 2014: a year in review. Artif Organs. 2015;39:260–87.

    Article  PubMed  Google Scholar 

  58. Welman T, Michel S, Segaren N, Shanmugarajah K. Bioengineering for organ transplantation: progress and challenges. Bioengineered. 2015;6:257–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Chakkera HA, Kudva YC, Chang YH et al. (2015) Glucose homeostasis after simultaneous pancreas and kidney transplantation: a comparison of subjects with C-peptide positive non-type 1 diabetes mellitus and type 1 diabetes mellitus. Clin Transplant. Oct 20 [Epub ahead of print].

  60. Staels W, De Groef S, Heremans Y, et al. Accessory cells for β-cell transplantation. Diabetes Obes Metab. 2016;18:115–24.

  61. Okita K, Mizuguchi T, Shigenori O, et al. Pancreatic regeneration: basic research and gene regulation. Surg Today. 2016;46:633–40.

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Kochi Medical School, Kochi University, Kohasu, Okocho, Nankoku, Kochi, 783-8505, Japan

    Kazuhiro Hanazaki, Masaya Munekage, Hiroyuki Kitagawa, Eri Munekage, Mai Shiga, Hiromichi Maeda & Tsutomu Namikawa

  2. Department of Anesthesiology, Kochi Medical School, Kochi University, Kohasu, Okocho, Nankoku, Kochi, Japan

    Tomoaki Yatabe

Authors
  1. Kazuhiro Hanazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masaya Munekage
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroyuki Kitagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tomoaki Yatabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eri Munekage
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mai Shiga
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hiromichi Maeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tsutomu Namikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tsutomu Namikawa.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hanazaki, K., Munekage, M., Kitagawa, H. et al. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system. J Artif Organs 19, 209–218 (2016). https://doi.org/10.1007/s10047-016-0904-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10047-016-0904-y

Keywords

Search

Navigation